SIML Simlatus Corp

Satel Group and Simlatus Acquire Proscere Bioscience and Their Exclusive Licensing Rights for Cold-Water CBD Extraction Technology; and Appoints Baron Tennelle and Victoria Boltrick to the Board of Directors

Satel Group and Simlatus Acquire Proscere Bioscience and Their Exclusive Licensing Rights for Cold-Water CBD Extraction Technology; and Appoints Baron Tennelle and Victoria Boltrick to the Board of Directors

San Francisco, California, Feb. 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK:SIML) (“Simlatus” or the “Company”), Satel Group announced the merger with Simlatus in November 2018, and the merger resulted in the expansion of Satel’s San Francisco based internet business. Today, Satel Group and Simlatus announce the acquisition rights of cold-water CBD Extraction Technology and various agricultural products for the aeroponics industry.

Richard Hylen, Chairman and CEO, stated, “We have a tremendous amount of excitement in announcing the acquisition of the technology and manufacturing of Cold-Water CBD Extraction systems. Although Satel Group is very focused on growing our existing revenue stream alongside of Simlatus, we are adding an additional revenue stream to diversify our business model. I have strong relationships with various technologies, and I have been able to negotiate the acquisition of cold-water CBD extraction and aeroponic agricultural products, as well as, expand the Board of Directors with the appointment of Baron Tennelle and Victoria Boltrick.”

Mr. Hylen further stated, “Our auditors, M&K, have suggested changing our fiscal year ending to December 31; therefore we will be disclosing this change and file our Form 10-K on or before March 31, 2019. We plan to restructure the public company as a Holding Company, and it will wholly own the three subsidiaries “Satel Group Inc.”, “Simlatus Corporation”, and “Proscere Bioscience Inc.” We will keep our shareholders and public informed on a more frequent basis as we grow this dynamic portfolio of revenue producing companies.”

Safe Harbor for Forward-Looking Statements: This news release includes forward-looking statements. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The Company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are and will be set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.

Contact:

Richard Hylen, CEO tel:(530) 205-3437
EN
14/02/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Simlatus Corp

 PRESS RELEASE

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System SAN FRANCISCO, CA, Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a holding company currently focused on opportunities in the cannabis space that owns and operates a number of subsidiaries, all with multiple revenue streams, diversified in cannabis processing products, commercial broadcasting and support services to AT&T’s DirecTV products. Today the company announces that it has received another purchase order from United Opportunities LLC on ...

 PRESS RELEASE

SIML Proscere Bioscience Positions Long Term Strategy

SIML Proscere Bioscience Positions Long Term Strategy San Francisco, California, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the company’s diver...

 PRESS RELEASE

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor San Francisco, California, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the com...

 PRESS RELEASE

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD...

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD/Hemp Extraction Systems from Brand House Ventures Inc. San Francisco, California, July 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’...

 PRESS RELEASE

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Ind...

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Industry With NASDAQ on the Horizon San Francisco, California, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on t...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch